source
- Eli Lilly says its GLP-1 weight loss shot and pill now covered for millions of AmericansEli Lilly announced that its GLP-1 based weight-loss injection and oral medication have been added to the formularies of the three largest pharmacy benefit managers. The company said this move make…
- Mineralys Therapeutics raises funds ahead of pending lorundrostat hypertension approvalMineralys Therapeutics first came to market attention in 2021 when it licensed a novel hypertension candidate, lorundrostat, from Japan’s Tanabe Pharma, agreeing to a modest $1 million upfront paym…